Literature DB >> 20388508

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

J Löfblom1, J Feldwisch, V Tolmachev, J Carlsson, S Ståhl, F Y Frejd.   

Abstract

Affibody molecules are a class of engineered affinity proteins with proven potential for therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5 kDa) single domain proteins that can be isolated for high affinity and specificity to any given protein target. Fifteen years after its discovery, the Affibody technology is gaining use in many groups as a tool for creating molecular specificity wherever a small, engineering compatible tool is warranted. Here we summarize recent results using this technology, propose an Affibody nomenclature and give an overview of different HER2-specific Affibody molecules. Cumulative evidence suggests that the three helical scaffold domain used as basis for these molecules is highly suited to create a molecular affinity handle for vastly different applications. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388508     DOI: 10.1016/j.febslet.2010.04.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  187 in total

Review 1.  Molecular imaging with SERS-active nanoparticles.

Authors:  Yin Zhang; Hao Hong; Duane V Myklejord; Weibo Cai
Journal:  Small       Date:  2011-09-20       Impact factor: 13.281

Review 2.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.

Authors:  Oleg Y Dmitriev; Svetlana Lutsenko; Serge Muyldermans
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

Review 3.  Targeting recognition surfaces on natural proteins with peptidic foldamers.

Authors:  James W Checco; Samuel H Gellman
Journal:  Curr Opin Struct Biol       Date:  2016-07-05       Impact factor: 6.809

Review 4.  Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Authors:  Y Ardeshirpour; V Chernomordik; J Capala; M Hassan; R Zielinsky; G Griffiths; S Achilefu; P Smith; A Gandjbakhche
Journal:  Technol Cancer Res Treat       Date:  2011-12

Review 5.  Single-molecule detection and tracking in plants.

Authors:  Markus Langhans; Tobias Meckel
Journal:  Protoplasma       Date:  2014-01-03       Impact factor: 3.356

6.  Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.

Authors:  Yanqiu Zhang; Mengru Wang; Wanhua Liu; Xin Peng
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

7.  Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.

Authors:  Lawrence A Stern; Patrick S Lown; Alexandra C Kobe; Lotfi Abou-Elkacem; Juergen K Willmann; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2019-01-24       Impact factor: 3.784

8.  64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor.

Authors:  Max A Kruziki; Brett A Case; Jie Y Chan; Elizabeth J Zudock; Daniel R Woldring; Douglas Yee; Benjamin J Hackel
Journal:  Mol Pharm       Date:  2016-10-10       Impact factor: 4.939

9.  Advancing Molecular-Guided Surgery through probe development and testing in a moderate cost evaluation pipeline.

Authors:  Brian W Pogue; Keith D Paulsen; Sally M Hull; Kimberly S Samkoe; Jason Gunn; Jack Hoopes; David W Roberts; Theresa V Strong; Daniel Draney; Joachim Feldwisch
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-04

10.  Molecular imaging of insulin-like growth factor 1 receptor in cancer.

Authors:  Yin Zhang; Weibo Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.